Donanemab drug slows Alzheimer's by 60% for mildly impaired patients in trial

More than 55 million people worldwide have Alzheimer's or other forms of dementia, claims WHO

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,Boston ,Massachusetts ,United States ,Americans ,Liz Coulthard ,Anne White ,Reisa Sperling ,Eli Lilly ,Susan Kohlhaas ,Un World Health Organization ,Alzheimer Association International Conference ,Alzheimer Association ,University Of Bristol ,Reuters ,New York Stock Exchange ,Indiana University School Of Medicine ,Drug Administration ,York Stock Exchange ,Alzheimer Research ,Alzheimer Research United Kingdom ,Association International Conference ,Research United Kingdom ,Liana Apostolova ,Indiana University School ,New York Stock ,Donanemab Drug Slows Alzheimers By 60 For Mildly Impaired Patients In Trial ,